Publications by authors named "A Jeppsson"
Objective: Postoperative atrial fibrillation (POAF) is a common complication after cardiac surgery that is associated with other adverse outcomes. Recent studies have shown that drainage of pericardial effusion by a posterior pericardial incision reduces the incidence of POAF. An alternative approach is a chest tube placed posteriorly in the pericardium.
View Article and Find Full Text PDFThe human heart regenerates slowly through life, but how new cells are generated is mostly unknown. The atrioventricular junction (AVj) has been indicated as a potential stem cell niche region. Little is known about the protein composition of the human AVj.
View Article and Find Full Text PDFBackground And Aims: The long-term outcomes of percutaneous coronary intervention (PCI) vs. coronary artery bypass grafting (CABG) in patients with non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel disease remain debated.
Methods: The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies registry was used to analyse 57 097 revascularized patients with NSTEMI with multivessel disease in Sweden from January 2005 to June 2022.
Background: Cardiomyocytes in the adult human heart show a regenerative capacity, with an annual renewal rate of ≈0.5%. Whether this regenerative capacity of human cardiomyocytes is employed in heart failure has been controversial.
View Article and Find Full Text PDFArticle Synopsis
- - New-onset postoperative atrial fibrillation (POAF) is common after cardiac surgery, particularly coronary artery bypass grafting (CABG), with an estimated incidence of about 30%, but it’s often temporary and under-detected.
- - Previous studies on POAF have used intermittent monitoring techniques that may miss many cases, leading to inaccurate assessments of how often arrhythmias occur post-surgery.
- - The CABG-AF study aims to get a clearer picture of AF incidence and patterns after CABG by using continuous monitoring with an insertable cardiac device in 196 patients, tracking episodes over a planned follow-up of three years.